Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study

References

• Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 2020;79:685–99.
   PubMed Web of Science ®Google Scholar
• Nagy G, Roodenrijs NM, Welsing PM, Kedves M, Hamar A, van der Goes MC, et al. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2021;80:31–5.
   PubMed Web of Science ®Google Scholar
• Roodenrijs NMT, van der Goes MC, Welsing PMJ, Tekstra J, Lafeber FPJG, Jacobs JWG, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatol (Oxford) 2021;60:3778–88.
   PubMed Web of Science ®Google Scholar
• Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D’Agostino M-A, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013;72:804–14.
   PubMed Web of Science ®Google Scholar
• Nagy G, Roodenrijs NMT, Welsing PMJ, Kedves M, Hamar A, van der Goes MC, et al. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2022;81:20–33.
   PubMed Web of Science ®Google Scholar
• Filippou G, Sakellariou G, Scirè CA, Carrara G, Rumi F, Bellis E, et al. The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian Multicentre Study of the Italian Society for Rheumatology Group for Ultrasound: the STA. Ann Rheum Dis 2018;77:1283–9.
   PubMed Web of Science ®Google Scholar
• Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and spondyloarthritis: a systematic review and meta-analysis. Rheumatol (Oxford) 2018;57:1453–60.
   PubMed Web of Science ®Google Scholar
• Mülkoğlu C, Ayhan FF. The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: a cross-sectional study. Mod Rheumatol 2021;31:827–33.
   PubMed Web of Science ®Google Scholar
• Nishino A, Kawashiri S-Y, Koga T, Iwamoto N, Ichinose K, Tamai M, et al. Ultrasonographic efficacy of biologic and targeted synthetic disease-modifying antirheumatic drug therapy in rheumatoid arthritis from a multicenter rheumatoid arthritis ultrasound prospective cohort in Japan. Arthritis Care Res (Hoboken) 2018;70:1719–26.
   PubMed Web of Science ®Google Scholar
• Endo Y, Kawashiri S-Y, Morimoto S, Nishino A, Okamoto M, Tsuji S, et al. Non-TNF inhibitor switchers versus TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan. Immunol Med 2020;43:115–20.
   PubMedGoogle Scholar
• Endo Y, Kawashiri S-Y, Nishino A, Okamoto M, Tsuji S, Shimizu T, et al. Discrepancy between clinical and ultrasound remissions in rheumatoid arthritis: a multicentre ultrasound cohort study in Japan. Scand J Rheumatol 2021;50:436–41.
   PubMed Web of Science ®Google Scholar
• Endo Y, Kawashiri S-Y, Morimoto S, Nishino A, Okamoto M, Tsuji S, et al. Utility of a simplified ultrasonography scoring system among patients with rheumatoid arthritis: a multicenter cohort study. Medicine (Baltimore) 2021;100:e23254.
   PubMed Web of Science ®Google Scholar
• Kawashiri S-Y, Endo Y, Nishino A, Okamoto M, Tsuji S, Takatani A, et al. Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA): a multicenter RA ultrasound prospective cohort in Japan. Medicine (Baltimore) 2021;100:e26592.
   PubMed Web of Science ®Google Scholar
• Kawashiri S-Y, Endo Y, Nishino A, Okamoto M, Tsuji S, Takatani A, et al. Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan. BMC Musculoskelet Disord 2021;22:506.
   PubMed Web of Science ®Google Scholar
• Endo Y, Kawashiri S-Y, Nishino A, Michitsuji T, Tomokawa T, Nishihata S, et al. Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan. Scand J Rheumatol 2022;51:259–67.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81.
   PubMed Web of Science ®Google Scholar
• Kristensen LE, Saxne T, Geborek P. The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden. Arthritis Rheum 2006;54:600–6.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
   PubMed Web of Science ®Google Scholar
• Lumley T. Survey: analysis of complex survey samples. R Package version. 2012.
   Google Scholar
• Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. J Am Stat Assoc 2018;113:390–400.
   Web of Science ®Google Scholar
• Takanashi S, Kaneko Y, Takeuchi T. Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice. Rheumatol (Oxford) 2021;60:5247–56.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Hashimoto M, Murata K, Murakami K, Tanaka M, Ohmura K, et al. Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort. Immunol Med 2022;45:35–44.
   PubMedGoogle Scholar
• Tan YK, Li H, Allen JCJ, Thumboo J. Ultrasound power Doppler and gray scale joint inflammation: what they reveal in rheumatoid arthritis. Int J Rheum Dis 2019;22:1719–23.
   PubMedGoogle Scholar
• Ochi S, Sonomoto K, Nakayamada S, Tanaka Y. Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry. Arthritis Res Ther 2022;24:61.
   PubMed Web of Science ®Google Scholar
• Novella-Navarro M, Plasencia C, Tornero C, Navarro-Compán V, Cabrera-Alarcón JL, Peiteado-López D, et al. Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis. Arthritis Res Ther 2020;22:284.
   PubMedGoogle Scholar